References
Rouprêt M, Babjuk M, Compérat E et al (2013) European association of urology. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63(6):1059–1071. doi:10.1016/j.eururo.2013.03.032
Johnson GB, Grasso M (2005) Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr Opin Urol 15:89–93
Cutress ML, Stewart GD, Wells-Cole S et al (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int 110(11):1608–1617. doi:10.1111/j.1464-410X.2012.11169.x
Adamis S, Varkarakis J (2011) Minimally invasive approach in the management of upper-urinary-tract tumours. Scand J Urol Nephrol 45(6):381–387. doi:10.3109/00365599.2011.590999
Fajkovic H, Klatte T, Nagele U et al (2013) Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience. World J Urol 31(1):37–44. doi:10.1007/s00345-012-0948-4
Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol 23:341–346. doi:10.1089/end.2008.0251
Chen GL, Bagley DH (2001) Ureteroscopic surgery for upper tract transitional cell carcinoma: complications and management. J Endourol 15:399–404
Cornu JN, Rouprêt M, Carpentier X et al (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28(2):151–156. doi:10.1007/s00345-009-0494-x
Bader M, Sroka R, Gratzke C et al (2009) Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur Urol 56(1):65–71. doi:10.1016/j.eururo.2008.12.012
Oelke M, Bachmann A, Descazeaud A (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118–140. doi:10.1016/j.eururo.2013.03.004
Gao X, Ren S, Xu C et al (2008) Thulium laser resection via a flexible cystoscope for recurrent non-muscle invasive bladder cancer: initial clinical experience. BJU Int 102:1115–1118
Muto G, Collura D, Giacobbe A et al (2014) Thulium: yttrium-aluminum garnet laser for En Bloc Resection of Bladder Cancer: clinical and histopathologic advantages. Urology 83:851–855
Kramer MW, Abdelkawi IF, Wolters M, Bach T, Gross AJ, Nagele U, Conort P, Merseburger AS, Kuczyk MA, Herrmann TR (2014) Current evidence for transurethral en bloc resection of non-muscle-invasive bladder cancer. Minim Invasive Ther Allied Technol 23(4):206–213
Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, Merseburger AS, Herrmann TR (2014) Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer. World J Urol. doi:10.1007/s00345-014-1337-y
Bach T, Huck N, Wezel F et al (2010) 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex vivo evaluation. BJU Int 106(3):368–372. doi:10.1111/j.1464-410X.2009.09059.x
Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19:25–31
Teichmann HO, Herrmann TR, Bach T (2007) Technical aspects of lasers in urology. World J Urol 25(3):221–225
Marks AJ, Teichmann JMH (2007) Laser in clinical urology: state of the art and new horizons. World J Urol 25:227–233
Defidio L, De Dominicis M, Gianfrancesco Di et al (2011) First collaborative experience with thulium laser ablation of localized upper urinary tract urothelial tumors using retrograde intra-renal surgery. Arch Ital Urol Androl 83(3):147–153
LisaLaser® USA Revolix® information sheet. http://www.lisalaserusa.com/urology/. Accessed 22 Nov 2014
F.D.A access data, 510(k) summary of safety and effectiveness information according 21 CFR Part 807.87(h). Indication of use of vela®XL laser system. http://www.accessdata.fda.gov/cdrh_docs/pdf10/K103654.pdf. Accessed 22 Nov 2014
F.D.A access data (2013) Attachment V, 510 (k) summary. Indication of use of RevoLix Jr, RevoLix 120 watt and Quanta Cyber TM 150. http://www.accessdata.fda.gov/cdrh_docs/pdf11/k110941.pdf. Accessed 20 Nov 2014
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Emiliani, E., Herrmann, T.R.W. & Breda, A. Thulium laser for the treatment of upper urinary tract carcinoma (UTUC)? Are we there, yet?. World J Urol 33, 595–597 (2015). https://doi.org/10.1007/s00345-015-1511-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-015-1511-x